Talk:Affymetrix

message: I didn't start the word-crafting on the 'patent portfolio' section of the introductory paragraph, but I'm hoping to end it.  The original statement was *ahem* very POV: "The company has an impressive patent portfolio in this area".  I subsequently toned this down to read: "Affymetrix has a valuable patent portfolio".  In the face of opposition to this toned down version, I've revised it a second time, so that it now reads: "Affymetrix derives significant benefit from its patent portfolio in this area".
A company's patent portfolio can be described as 'valuable' but the question is in what context.  For instance, without patent protection, most pharmaceutical companies would outright die ... the patent portfolio is not only valuable to them, but 'life giving'.  Some companies exist only to secure and trade patent rights; in those cases, patents are the companies.  I suppose the question comes down to asking whether "the Hope Diamond is valuable" is a POV-statement or not, as the same logic would apply in this case, that the patent portfolio is valuable but less so or more so depending on the context in which the value is perceived. --User:Ceyockey (talk to me) 14:54, 3 December 2006 (UTC)
replies: text: "Valuable" is subjective.  "Has been appraised at a worth of X millions of dollars" is not.  "Considered valuable by X commentator" is not.  Subjective determinations need to be sourced to whoever's making the judgment. Night Gyr (talk/Oy) 19:39, 3 December 2006 (UTC)
thread_title: 'Patent portfolio' wording

message: as a scientist who works at for profit competitors of affy, i can tell you that their patent estate has been extremely valuable - it really helped get affy huge amounts of biz by keeping others out.
I don't have ref's handy, and am not sure i want to spend more time, as microarrrays are dying in the face of high speed dna sequencing (which delivers the same kind of info, but in a much better way)
also, affy is clearly loosing market share to illumina.  —Preceding unsigned comment added by Cinnamon colbert (talk • contribs) 16:28, 7 January 2009 (UTC)
thread_title: is valuable quick note

message: Not sure at this point if he cares to be remembered as the founder of Affymax/Affymetrix, but Alex Zaffaroni started this company.  Here is a link to an article which mentions this.
http://www.forbes.com/forbes/2000/0501/6510154s2_print.html Psredpoppy (talk) 07:45, 26 February 2013 (UTC)
thread_title:  Founder of Affymax 

message: Can the article cite when the first microarray was sold and/or created by Affymetrix? Right now neither here, nor in the DNA Microarrays wikipedia article, is this mentioned. 2A02:8388:1600:C80:BE5F:F4FF:FECD:7CB2 (talk) 15:53, 21 June 2016 (UTC)
thread_title:  History of DNA microarrays 

message: Affymetrix (former ticker symbol AFFX), was acquired by Thermo-Fisher (ticker symbol TMO) on 31 March 2016.
https://www.genomeweb.com/business-news/thermo-fisher-completes-acquisition-affymetrix
71.139.161.30 (talk) 07:07, 23 October 2016 (UTC)
thread_title:  Acquired 

message: As of 8/6/2017, this article was a mix of pre-acquisition present tense and post-acquisition past-tense, but in either case it described Affymetrix as a company.  Someone in the know should consider a significant overhaul to the language (though not necessarily the content) to frame Affymetrix as an entity that was a company and is now a product line / brand within ThermoFisher.  The current past tense of the article (or at least the header), while better than the ambiguous mix that preceded it, loosely implies that Affmyetrix no longer exists; this is not true, but it's not quite right to call it a company, and I'm not sure it's even quite right to call it a subsidiary now (because I'm not in the know); AFAIK it's a historical company and a current product line.
LittleWalrus (talk) 20:08, 6 August 2017 (UTC)
thread_title:  No longer a company, now a product line